Litcius/Paper detail

Loss of MAT2A compromises methionine metabolism and represents a vulnerability in H3K27M mutant glioma by modulating the epigenome

Brian Golbourn, Matthew Halbert, Katharine Halligan, Srinidhi Varadharajan, Brian Krug, Nneka E. Mbah, Nisha Kabir, Ann-Catherine J. Stanton, Abigail L. Locke, Stephanie M. Casillo, Yanhua Zhao, Lauren Sanders, Allison Cheney, Steven J. Mullett, Apeng Chen, Michelle Wassell, Anthony Andren, Jennifer Pérez, Esther P. Jane, Daniel R. Premkumar, Robert F. Koncar, Shideh Mirhadi, Lauren McCarl, Yue‐Fang Chang, Yijen Wu, Taylor Gatesman, Andrea Cruz, Michal Zápotocký, Baoli Hu, Gary Kohanbash, Xiuxing Wang, Alenoush Vartanian, Michael F. Moran, Frank S. Lieberman, Nduka Amankulor, Stacy G. Wendell, Olena M. Vaske, Ashok Panigrahy, James Felker, Kelsey C. Bertrand, Claudia L. Kleinman, Jeremy N. Rich, Robert M. Friedlander, Alberto Broniscer, Costas A. Lyssiotis, Nada Jabado, Ian F. Pollack, Stephen C. Mack, Sameer Agnihotri

2022Nature Cancer92 citationsDOIOpen Access PDF

Topics & Concepts

MethionineChromatinMethionine AdenosyltransferaseEpigenomeBiologyEpigeneticsCell cycleVulnerability (computing)Cell biologyLysineCancer researchChemistryCellBiochemistryAmino acidDNA methylationGene expressionGeneComputer scienceComputer securityGlioma Diagnosis and TreatmentEpigenetics and DNA MethylationRNA modifications and cancer
Loss of MAT2A compromises methionine metabolism and represents a vulnerability in H3K27M mutant glioma by modulating the epigenome | Litcius